Gunderson Capital Management’s IceCure Medical ICCM Stock Holding History

Gunderson Capital Management’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-667	Closed	-$6.02K	–	56
2026 Q1	$6.02K	Hold	667	–	–	﹤0.01%	46
2025 Q4	$12.2K	Hold	667	–	–	0.01%	40
2025 Q3	$20.3K	Hold	667	–	–	0.01%	53
2025 Q2	$19.9K	Buy	+667	New	+$21.5K	0.01%	47

Other funds holding ICCM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Gunderson Capital Management's ICCM Position: Q2 2026 in Review

Gunderson Capital Management sold out of IceCure Medical (ICCM) in Q2 2026, closing a stake of 667 shares — an estimated $6.02K sold.

Gunderson Capital Management first reported a position in ICCM in Q2 2025 and held it in 4 quarters. The position peaked at $20.3K in Q3 2025. 3 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.

Gunderson Capital Management reported no remaining IceCure Medical position as of Q2 2026 after selling out during the quarter.
Gunderson Capital Management sold 667 IceCure Medical shares in Q2 2026, an estimated $6.02K.
Gunderson Capital Management first reported a position in IceCure Medical in Q2 2025 and held it in 4 quarters.
Gunderson Capital Management's IceCure Medical position peaked at $20.3K in Q3 2025.
3 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.

Based on Gunderson Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.